|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.010 SGD | 0.00% |
|
0.00% | -0.98% |
| 05/12 | Raffles Medical Buys Back More Shares | MT |
| 30/25/30 | Raffles Medical Appoints CFO | MT |
| Capitalization | 185.86Cr 144.61Cr 123.83Cr 115.16Cr 107.36Cr 200.61Cr 13TCr 215.17Cr 1.33TCr 521.45Cr 6.24TCr 542.32Cr 531.2Cr 23TCr | P/E ratio 2025 * |
27.4x | P/E ratio 2026 * | 25.3x |
|---|---|---|---|---|---|
| Enterprise value | 153.3Cr 119.28Cr 102.14Cr 95Cr 89Cr 165.47Cr 11TCr 177.48Cr 1.09TCr 430.11Cr 5.14TCr 447.32Cr 438.15Cr 19TCr | EV / Sales 2025 * |
1.95x | EV / Sales 2026 * | 1.79x |
| Free-Float |
39.43% | Yield 2025 * |
2.89% | Yield 2026 * | 2.61% |
| Current month | -0.98% | ||
| 3 months | -0.98% | ||
| 6 months | -1.94% | ||
| Current year | -0.98% |
| 1 week | 1 |  | 1.02 |
| 1 month | 1 | | 1.02 |
| Current year | 1 | | 1.02 |
| 1 year | 0.82 | | 1.09 |
| 3 years | 0.82 | | 1.52 |
| 5 years | 0.82 | | 1.58 |
| 10 years | 0.73 | | 1.68 |
| Manager | Title | Age | Since |
|---|---|---|---|
Alfred Loh
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/1976 |
Yeng Yeng Woo
DFI | Director of Finance/CFO | 50 | 10/10/2025 |
Kenneth Wu
COO | Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Choon Yong Loo
CHM | Chairman | 76 | 16/05/1989 |
Soo Nan Tan
BRD | Director/Board Member | 78 | 28/07/2000 |
Tse Ghow Lim
BRD | Director/Board Member | 62 | 01/10/2014 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | +21.69% | -26.81% | 144.61Cr | |
| +0.48% | -0.73% | +56.63% | +85.90% | 11TCr | |
| +0.07% | -0.07% | +67.38% | -9.89% | 10TCr | |
| -0.81% | +5.60% | +45.80% | +77.32% | 3.34TCr | |
| 0.00% | +6.79% | -12.93% | +19.05% | 2.44TCr | |
| -0.56% | -1.10% | +7.93% | -0.77% | 2.08TCr | |
| +0.86% | +1.41% | +15.91% | +18.78% | 1.96TCr | |
| -0.79% | -3.57% | +55.98% | +290.24% | 1.75TCr | |
| -0.07% | +0.51% | +57.94% | +53.30% | 1.69TCr | |
| -0.52% | -7.59% | +12.59% | +40.89% | 1.29TCr | |
| Average | -0.13% | +0.17% | +32.89% | +54.80% | 3.57TCr | |
| Weighted average by Cap. | +0.05% | +0.39% | +47.18% | +50.87% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 78Cr 61Cr 52Cr 49Cr 45Cr 85Cr 5.5TCr 91Cr 559.8Cr 220.04Cr 2.63TCr 228.85Cr 224.16Cr 9.65TCr | 83Cr 64Cr 55Cr 51Cr 48Cr 89Cr 5.79TCr 96Cr 589.11Cr 231.57Cr 2.77TCr 240.83Cr 235.9Cr 10TCr |
| Net income | 6.84Cr 5.32Cr 4.56Cr 4.24Cr 3.95Cr 7.38Cr 479.75Cr 7.92Cr 49Cr 19Cr 229.51Cr 20Cr 20Cr 841.53Cr | 7.47Cr 5.81Cr 4.98Cr 4.63Cr 4.32Cr 8.07Cr 524.02Cr 8.65Cr 53Cr 21Cr 250.69Cr 22Cr 21Cr 919.19Cr |
| Net Debt | -33Cr -25Cr -22Cr -20Cr -19Cr -35Cr -2.28TCr -38Cr -232.39Cr -91Cr -1.09TCr -95Cr -93Cr -4TCr | -38Cr -30Cr -25Cr -24Cr -22Cr -41Cr -2.66TCr -44Cr -271.17Cr -106.59Cr -1.27TCr -110.86Cr -108.59Cr -4.67TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/26/13 | 1.010 $ | 0.00% | 11,10,200 |
| 12/26/12 | 1.010 $ | 0.00% | 6,17,900 |
| 09/26/09 | 1.010 $ | -0.98% | 3,99,500 |
| 08/26/08 | 1.020 $ | +0.99% | 3,98,600 |
| 07/26/07 | 1.010 $ | -0.98% | 10,93,500 |
Delayed Quote Singapore S.E., January 13, 2026 at 02:29 pm IST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Annual profits - Rate of surprise
- Stock Market
- Equities
- BSL Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition